Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2Cd.4Cl.5H2O |
| Molecular Weight | 456.71 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Cl-].[Cd++].[Cd++]
InChI
InChIKey=DZVRGWYMCGLNKJ-UHFFFAOYSA-J
InChI=1S/2Cd.4ClH.5H2O/h;;4*1H;5*1H2/q2*+2;;;;;;;;;/p-4
Cadmium is a heavy metal that causes toxicity in humans and animals. Cadmium chloride is used due to its solubility in water and its ability to produce high concentrations of cadmium at the target site. Cadmium chloride is used in printing, photocopying, dyeing, analytical chemistry. Experiments on rodents have shown that this compound caused renal toxicity. Oxidative stress plays a key role in cadmium chloride-induced cyto/genotoxicity.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The protective role of ascorbic acid in the hepatotoxicity of cadmium and mercury in rabbits. | 2019-05 |
|
| Cadmium Chloride Induces DNA Damage and Apoptosis of Human Liver Carcinoma Cells via Oxidative Stress. | 2016-01-02 |
|
| Effects of Maternal Exposure to Cadmium Oxide Nanoparticles During Pregnancy on Maternal and Offspring Kidney Injury Markers Using a Murine Model. | 2015 |
|
| Cadmium associated with inhaled cadmium oxide nanoparticles impacts fetal and neonatal development and growth. | 2012-04 |
|
| Effects of particulate and soluble cadmium species on biochemical and functional parameters in cultured murine macrophages. | 2000 |
|
| Inhibition of HIV-1 infection by zinc group metal compounds. | 1999-09 |
|
| Effects of trace metal compounds on HIV-1 reverse transcriptase: an in vitro study. | 1999-05 |
|
| Zinc inhibition of renin and the protease from human immunodeficiency virus type 1. | 1991-09-10 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID4040183
Created by
admin on Mon Mar 31 18:19:40 GMT 2025 , Edited by admin on Mon Mar 31 18:19:40 GMT 2025
|
PRIMARY | |||
|
2R707SXC9H
Created by
admin on Mon Mar 31 18:19:40 GMT 2025 , Edited by admin on Mon Mar 31 18:19:40 GMT 2025
|
PRIMARY | |||
|
16211524
Created by
admin on Mon Mar 31 18:19:40 GMT 2025 , Edited by admin on Mon Mar 31 18:19:40 GMT 2025
|
PRIMARY | |||
|
7790-78-5
Created by
admin on Mon Mar 31 18:19:40 GMT 2025 , Edited by admin on Mon Mar 31 18:19:40 GMT 2025
|
PRIMARY | |||
|
63938
Created by
admin on Mon Mar 31 18:19:40 GMT 2025 , Edited by admin on Mon Mar 31 18:19:40 GMT 2025
|
PRIMARY | |||
|
m2892
Created by
admin on Mon Mar 31 18:19:40 GMT 2025 , Edited by admin on Mon Mar 31 18:19:40 GMT 2025
|
PRIMARY | Merck Index | ||
|
300000053133
Created by
admin on Mon Mar 31 18:19:40 GMT 2025 , Edited by admin on Mon Mar 31 18:19:40 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
